Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Heart Journal

• Publication date

  2011-07-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/eurheartj/ehr238PMID 21785107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward.

  2011cited by this paper
• β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure.

  2011cited by this paper
• Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate

  2010cited by this paper
• Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

  2010cited by this paper
• Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure.

  2010cited by this paper
• Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure.

  2010cited by this paper
• Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure.

  2010influential reference
• Postdischarge assessment after a heart failure hospitalization: the next step forward.

  2010cited by this paper
• Heart failure: Early follow-up after hospitalization for heart failure

  2010cited by this paper
• Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes: Lessons Learned and Directions Forward

  2010cited by this paper
• Acute kidney injury increases risk of ESRD among elderly.

  2009cited by this paper
• Role of the kidney in congestive heart failure.

  2009cited by this paper
• Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease.

  2009cited by this paper
• Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial.

  2009cited by this paper
• Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group.

  2009cited by this paper
• Both in‐ and out‐hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH)

  2009influential reference
• Role of remission clinics in the longitudinal treatment of CKD.

  2008cited by this paper
• Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge Survival: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)

  2008cited by this paper
• Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance

  2008cited by this paper
• Cardiorenal interactions: insights from the ESCAPE trial.

  2008cited by this paper
• Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

  2007cited by this paper
• Testing for chronic kidney disease: a position statement from the National Kidney Foundation.

  2007cited by this paper
• High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database.

  2007cited by this paper
• Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.

  2007cited by this paper
• Renal impairment and outcomes in heart failure: systematic review and meta-analysis.

  2006cited by this paper
• Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST).

  2005cited by this paper
• Acute Heart Failure Syndromes: Current State and Framework for Future Research

  2005cited by this paper
• Preventing microalbuminuria in type 2 diabetes.

  2005cited by this paper
• Renal Insufficiency and Heart Failure: Prognostic and Therapeutic Implications From a Prospective Cohort Study

  2004cited by this paper
• Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results.

  2004cited by this paper
• Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.

  2004cited by this paper
• Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease

  2004cited by this paper
• Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

  2004cited by this paper
• clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification

  2002cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• The prognostic importance of different definitions of worsening renal function in congestive heart failure.

  2002cited by this paper
• Cardiorenal risk: an important clinical intersection.

  2002cited by this paper
• Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?

  2002cited by this paper
• Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

  2001cited by this paper
• Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure.

  2000cited by this paper
• Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure.

  2000cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

  1997cited by this paper
• Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial).

  1992cited by this paper
• Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

  1986cited by this paper
• Role of Angiotensin II in the Altered Renal Function of Congestive Heart Failure

  1984cited by this paper
• EDEMA AND DECREASED RENAL BLOOD FLOW IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE: EVIDENCE OF "FORWARD FAILURE" AS THE PRIMARY CAUSE OF EDEMA.

  1946cited by this paper

• Systematic Review on the Management of Diuretic Resistance in Acute Heart Failure across the Spectrum of Kidney Disease

  2025influential citation
• Assessing volume status in heart failure: The role of renal duplex ultrasound in evaluating cardiorenal morbidity and heart failure mortality

  2025cites this paper
• Assessment of Decongestion Status Before Discharge in Acute Decompensated Heart Failure: A Review of Clinical, Biochemical, and Imaging Tools and Their Impact on Management Decisions

  2025influential citation
• Interest of Lung Ultrasound in the Management of Acute Heart Failure in Post-Emergency Service

  2025cites this paper
• Renal Recovery after Heart Transplantation in Patients With Type 1 Cardiorenal Syndrome Requiring Dialysis: Insights From a Cohort Without Mechanical Circulatory Support

  2025cites this paper
• Therapy gaps for patients with heart failure and reduced kidney function: A prospective cohort study

  2025influential citation
• Factors affecting prolonged hospital stay in a case of heart failure: a cross-sectional study

  2025cites this paper
• Relationship between clinical congestion and worsening renal function after intravenous initiation of furosemide in patients with acute heart failure

  2024cites this paper
• Prevalence Of Cardiorenal Syndrome In Patients Admitted For Acute Decompensated Heart Failure And Its Correlation With In-Hospital Outcomes.

  2024cites this paper
• Risk factors of readmission and the impact of outpatient management in heart failure patients: A national study in Japan

  2023cites this paper
• Prevalence, Clinical Characteristics, and Prognostic Impact of Kidney Disease on Heart Failure Patients: An Observational Study of the Colombian Heart Failure Registry

  2023cites this paper
• The role of bioimpedance analysis in overweight and obese patients with acute heart failure: a pilot study

  2023cites this paper
• Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC

  2023cites this paper
• Quantification and treatment of congestion in heart failure: A clinical and pathophysiological overview.

  2022cites this paper
• Impact of Non-cardiac Comorbidities on Long-Term Clinical Outcomes and Health Status After Acute Heart Failure in China

  2022cites this paper
• Risk Factors with 30-Day Readmission and the Impact of Length of Hospital Stay on It in Patients with Heart Failure: A Retrospective Observational Study Using a Japanese National Database.

  2022cites this paper
• Congestive Nephropathy

  2022influential citation
• Frontier and Hotspot Evolution in Cardiorenal Syndrome: a Bibliometric analysis from 2003 to 2022.

  2022cites this paper
• Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure

  2021cites this paper
• Quantification and Treatment of Congestion in Heart Failure: A Clinical and Pathophysiological Overview.

  2021cites this paper
• Avaliação da Função Renal em Pacientes com Insuficiência Cardíaca

  2021cites this paper
• Clinical and Echocardiographic Characteristics of Patients Hospitalized With Acute Versus Chronic Heart Failure With Preserved Ejection Fraction (From the ARIC Study).

  2021cites this paper
• Prognostic ability of mid-term worsening renal function after percutaneous coronary intervention: findings from the SHINANO registry

  2021cites this paper
• Arginine Vasopressin as an Important Mediator of Fluctuations in the Serum Creatinine Concentration Under Decongestion Treatment in Heart Failure Patients

  2021cites this paper
• Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction

  2020cites this paper
• Alterations in Kidney Function Associated With Heart Failure

  2020cites this paper
• Renal dysfunction in cardiovascular diseases and its consequences

  2020cites this paper
• Prognostic Impact of Changes in Intrarenal Venous Flow Pattern in Patients with Heart Failure.

  2020cites this paper
• Worsening Kidney Function Is the Major Mechanism of Heart Failure in Hypertension: The ALLHAT Study.

  2020cites this paper
• Incidence of, Associations With and Prognostic Impact of Worsening Renal Function in Heart Failure With Different Ejection Fraction Categories.

  2019cites this paper
• Heart Failure and Changes in Kidney Function: Focus on Understanding, Not Reacting.

  2019cites this paper
• A Balancing Act: Preserving Renal Function and the Need for Decongestion.

  2019cites this paper
• Tidal peritoneal dialysis versus ultrafiltration in type 1 cardiorenal syndrome: A prospective randomized study

  2019cites this paper
• The role of the kidney in acute and chronic heart failure

  2019cites this paper
• Implication of Acute Kidney Injury in Heart Failure.

  2019cites this paper
• Prognostic Impact of Worsening Renal Function in Hospitalized Heart Failure Patients With Preserved Ejection Fraction: A Report From the JASPER Registry.

  2019cites this paper
• WORSENING RENAL FUNCTION IN ACUTE DECOMPENSATED HEART FAILURE: A BAD SIGN, OR MAYBE NOT?

  2019cites this paper
• Cardiorenal syndrome type 1: a literature review

  2019cites this paper
• Cardiorenal biomarkers and therapeutic interventions in acute heart failure

  2019cites this paper
• Renal Dysfunction - a Possible Marker of Severity of Heart Failure

  2018cites this paper
• Negotiating renal dysfunction when treating patients with heart failure

  2018influential citation
• Puesta al dı́a : Insuficiencia cardiaca aguda ( III ) Sı́ndrome cardiorrenal en la insuficiencia cardiaca aguda : revisando paradigmas

  2018cites this paper
• Clinical effect of long-term administration of tolvaptan in patients with heart failure and chronic kidney disease.

  2018cites this paper
• Heart rate, pulse pressure and mortality in patients with myocardial infarction complicated by heart failure.

  2018cites this paper
• Renal dysfunction in heart failure : insights on prevalence and prognosis

  2018cites this paper
• Heart-Kidney Interactions in Cardiorenal Syndrome Type 1.

  2018cites this paper
• Bendopnea and risk of adverse clinical outcomes in ambulatory patients with systolic heart failure

  2017cites this paper
• Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes.

  2017cites this paper
• Initiation and Cessation Timing of Renal Replacement Therapy in Patients with Type 1 Cardiorenal Syndrome: An Observational Study

  2017cites this paper
• The paradox of transient worsening renal function in patients with acute heart failure: the role of B-type natriuretic peptide and diuretic response

  2017cites this paper
• Effect of carperitide on in-hospital mortality of patients admitted for heart failure: propensity score analyses

  2017cites this paper
• AKI and Long-Term Risk for Cardiovascular Events and Mortality.

  2017cites this paper
• Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload.

  2017cites this paper
• Contrasting acute and chronic effects of tolvaptan on serum osmolality in the EVEREST trial

  2016cites this paper
• Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure.

  2016cites this paper
• Novel biomarkers and therapies in cardiorenal syndrome.

  2016cites this paper
• Hemodynamic and neurochemical determinates of renal function in chronic heart failure.

  2016cites this paper
• Prevalence and prognostic impact of kidney disease on heart failure patients

  2016cites this paper
• Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact?

  2016cites this paper
• Ultrafiltration Therapy for Heart Failure: Balancing Likely Benefits against Possible Risks.

  2016cites this paper
• Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure

  2016cites this paper
• Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction.

  2016cites this paper
• Inhospital and Post-discharge Changes in Renal Function After Transcatheter Aortic Valve Replacement.

  2016cites this paper
• Organ protection possibilities in acute heart failure.

  2016cites this paper
• Incremental utility of prognostic variables at discharge for risk prediction in hospitalized patients with acutely decompensated chronic heart failure.

  2016cites this paper
• Prognostic significance of changes in cystatin C during treatment of acute cardiac decompensation.

  2016cites this paper
• Heart failure with multiple comorbidities

  2016cites this paper
• Diagnosis and Management of Heart Failure: An Investigation to Evaluate a Device to Measure Jugular Venous Pressure

  2016cites this paper
• Management of Congestion and Diuretic Resistance in Heart Failure

  2016cites this paper
• Time-dependent markers of comorbidity and prognosis in heart failure patients : transitions across the life course

  2016cites this paper
• Organ protection possibilities in acute heart failure.

  2016cites this paper
• Tolvaptan for Heart Failure, Systematic Review and Meta-Analysis of Trials

  2016cites this paper
• A Clinical Approach to the Acute Cardiorenal Syndrome.

  2015cites this paper
• Effect of renal function on prognosis in chronic heart failure.

  2015cites this paper
• Prognostic value of glomerular filtration rate estimation equations in acute heart failure with preserved versus reduced ejection fraction

  2015cites this paper
• Heart failure and comorbidities: renal failure, diabetes, atrial fibrillation, and inflammation.

  2015cites this paper
• Urine Osmolarity Predicts the Body Weight-Reduction Response to Tolvaptan in Chronic Kidney Disease Patients: A Retrospective, Observational Study

  2015cites this paper
• Carperitide Is Associated With Increased In-Hospital Mortality in Acute Heart Failure: A Propensity Score-Matched Analysis.

  2015cites this paper
• Síndrome cardiorrenal en la insuficiencia cardiaca aguda: revisando paradigmas

  2015cites this paper
• Renal Congestion in Heart Failure

  2015cites this paper
• Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial).

  2015cites this paper
• Heart Failure With Preserved Ejection Fraction: What Is in a Name?

  2015cites this paper
• Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin

  2015cites this paper
• Moving Towards a Novel Paradigm in Drug Development for Worsening Heart Failure: The T1 Model (Mechanistic Translational Phase)

  2015cites this paper
• Roadmap to inpatient heart failure management.

  2015cites this paper
• Strategies to Reduce Heart Failure Hospitalizations and Readmissions: How Low Can We Go?

  2015cites this paper
• Team-Based Care for Outpatients with Heart Failure.

  2015cites this paper
• H2H Strategies Associated with Reduced Heart Failure Readmission Rates in Georgia Hospitals

  2015cites this paper
• Clinical Investigations Carperitide Is Associated With Increased In-Hospital Mortality in Acute Heart Failure: A Propensity ScoreeMatched Analysis

  2015cites this paper
• Kidney disease in heart failure: the importance of novel biomarkers for type 1 cardio-renal syndrome detection

  2015cites this paper
• Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.

  2015cites this paper
• Hemoconcentration-guided diuresis in heart failure.

  2014cites this paper
• Prognostic significance of dilated inferior vena cava in advanced decompensated heart failure

  2014cites this paper
• Transient and persistent worsening renal function during hospitalization for acute heart failure.

  2014cites this paper
• Is there still a role for low-dose dopamine use in acute heart failure?

  2014cites this paper
• Hypotension During Hospitalization for Acute Heart Failure Is Independently Associated With 30-Day Mortality: Findings From ASCEND-HF

  2014cites this paper
• The Prognositic Significance of Serial Renal Function Measurements in Chronic Heart Failure

  2014cites this paper
• Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial

  2014cites this paper
• Synthesis and Biological Evaluation of Substituted Desloratadines as Potent Arginine Vasopressin V2 Receptor Antagonists

  2014cites this paper
• Ultra fi ltration is not Superior than Diuretics in Type 4 Cardiorenal Sydrome Tip

  2014cites this paper